Stroke Prevention in Hypertension Based on Pathogenesis Mechanisms


  • Legis Ocktaviana Saputri Departemen Farmakologi, Fakultas Kedokteran Universitas Mataram, Mataram, Indonesia
  • Herpan Syafii Harahap
  • Arina Windri Rivarti
  • Nurhidayati



stroke, hypertension, prevention, pathogenesis


Hypertension is a disease that causes death of 6.7% worldwide and is a major risk factor for stroke in Indonesia (79%). Approximately 60% of people with hypertension end in stroke, either hemorrhagic or ischemic stroke. As many as 40% of stroke cases can be prevented through good blood pressure (BP) management, however, other strategies are needed to maximize the reduction in the incidence of stroke in hypertensive patients. This literature study aims to find strategic gaps that can be developed for stroke prevention in hypertensive patients based on the mechanisms involved in its pathogenesis. Keyword combinations were used to search for peer-reviewed literature published on PubMed, Scopus, and Google Scholar. Various mechanisms are involved in the pathogenesis of stroke in hypertensive patients, including increased BP and blood pressure variability (VTD), baroreflex dysfunction, Angiotensin II (Ang II)-induced oxidative stress, and also inflammation involving the innate immune system. Stroke prevention strategies in hypertensive patients can be explored through the mechanisms involved, namely through blood pressure management, specific antioxidant and anti-inflammatory interventions, and administration of agents capable of modulating baroreflex. Prevention of stroke in hypertension based on the mechanism of pathogenesis can be a gap for further studies in reducing the incidence of stroke and preventing recurrent strokes.


Ahmad, S. & Ferrario, C. M. (2018). Chymase inhibitors for the treatment of cardiac diseases: a patent review (2010-2018). Expert Opin Ther Pat. 28(11): 755-764.

Appleton, J. P., Sprigg, N. & Bath, P. M. (2016). Blood Pressure Management in Acute Stroke. Stroke and Vascular Neurology, 2016(1): 72-82.

Boehme, A. K., Esenwa, C., & Elkind, M. S. V. (2017). Stroke Risk Factors, Genetics, and Prevention. Circulation Research, 120(3): 472-495.

Chiara, T.D., Coure, A. D., Daidone, M., Scaglione, S., Norrito, R. C., & Puleo, M. G. (2022). Pathogenetic Mechanisms of Hypertension–Brain-Induced Complications: Focus on Molecular Mediators. Int J Mol Sci. 23(5): 1-24.

Dikalov, S. I. & Nazarewicz, R. R. (2013). Angiotensin II- Induced Production of Mitochondrial Reactive Oxygen Species: Potential Mechanisms and Relevance for Cardiovascular Disease. Antioxid Redox Signal, 19(10): 1085–1094.

Ettehad, D., Emdin, C.A., Kiran, A., Anderson, S. G., Callender, T., Emberson, J., et al. (2016). Blood Pressure Lowering for Prevention of Cardiovascular Disease and Death: A Systematic Review and Meta Analysis. Lancet. 2016(387): 957-967.

Grilletti, J. V. F., Scapin, K.B., Bernardes, N., et al. (2018). Impaired Baroreflex Sensitivity and Increased Systolic Blood Pressure Variability in Chronic Post-Ischemic Stroke. CLINICS, 73(253): 1-4.

Gorelick, P. B., Whelton, P. K., Sorond, F., & Carey, R. M. (2020). Blood Pressure Management in Stroke.



How to Cite

Legis Ocktaviana Saputri, Harahap, H. S., Rivarti, A. W., & Nurhidayati. (2023). Stroke Prevention in Hypertension Based on Pathogenesis Mechanisms. Jurnal Kedokteran, 12(2), 171–179.



Literature Review

Most read articles by the same author(s)

1 2 > >>